South America Leukapheresis Market Growth Drivers and Forecast by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

South America Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

  • Report Date : Nov 2021
  • Report Code : TIPRE00025793
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 116

The leukapheresis market in South America is expected to grow from US$ 4.92 million in 2021 to US$ 7.89 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028.

Therapeutic apheresis refers to an extracorporeal treatment that involves the selective removal of cells or other targeted abnormal substances from blood circulation. The technique has lately been explored for the treatment of various medical conditions. Extracorporeal photopheresis (ECP) is a process that is used in the treatment of lymphoma. In this process, white blood cells (WBCs) are collected from the bloodstream, treated with light-activated drugs, and exposed to UV lights, followed by infusing it back to the patient body. Therapeutic plasma exchange is a potential method employed to treat medical conditions such as multiple sclerosis, myeloma, and leukemia. The technique withdraws plasma from the patient’s blood and replaces it with fresh donor plasma or bottled human albumin solution. Further, the double filtration plasmapheresis technique is used for rapidly progressive glomerulonephritis and low-density lipoprotein (LDL) apheresis or leukocytapheresis for the nephritic syndrome. These techniques are two major apheresis therapies that are used to treat kidney diseases. Thus, the widening scope of apheresis technology in therapeutics is emerging as a prevalent trend in the leukapheresis market.

South America have been witnessing a growing number of COVID-19 cases since its outbreak. The cases are increasing in Brazil, Argentina, and Colombia. The COVID-19 is expected to result in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor up by 45 million and the extremely poor number by 28 million. The COVID‐ 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South America. It suffers from severe inequalities. State-run hospitals and clinics are already overstressed by the treatment of vector‐borne diseases and community‐acquired infections and high rates of non‐communicable diseases (NCDs). Moreover, in South America, the Gross Domestic Product (GDP) and central government healthcare expenditure are significantly lower than in developed countries. In 2018, as per the United Nations, Economic Commission for Latin America (CEPAL), 16 South American countries invested less than 4% of their GDP to healthcare. The consequences of a lack of investment in public healthcare systems are reflecting during the pandemic. The COVID‐19 pandemic is exacerbating these inequalities by threatening the infrastructure and capacity of state‐owned healthcare systems. Thus, the factors mentioned above are negatively impacting the growth of the market in the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America leukapheresis market. The South America leukapheresis market is expected to grow at a good CAGR during the forecast period.
South America leukapheresis market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

South America Leukapheresis Market Segmentation

 

South America Leukapheresis Market – By Product Type

  • Leukapheresis Disposables
  • Leukapheresis Devices

South America Leukapheresis Market – By Application

  • Research Applications
  • Therapeutic Applications

South America Leukapheresis Market – By End User

  • Blood Component Providers and Blood Centers
  • Hospitals and Transfusion Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes

South America Leukapheresis Market – By Country

  • Brazil
  • Argentina
  • Rest of South America

South America Leukapheresis Market – Companies Mentioned

  • Asahi Kasei Corporation                                 
  • Fresenius SE & Co. KGaA                                
  • Haemonetics Corporation                               
  • Terumo Corporation                                        
  • STEMCELL Technologies Inc.                          
  • HemaCare  
  • Macopharma
  • AllCells
  • BioIVT                          

South America Leukapheresis Report Scope

Report Attribute Details
Market size in 2021 US$ 4.92 Million
Market Size by 2028 US$ 7.89 Million
Global CAGR (2021 - 2028) 7.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Leukapheresis Devices and Leukapheresis Disposables
By Application
  • Research Applications and Therapeutic Applications
By End User
  • Blood Component Providers and Blood Centers
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Transfusion Centers
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • BioIVT
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    1. Asahi Kasei Corporation                                 
    2. Fresenius SE & Co. KGaA                                
    3. Haemonetics Corporation                              
    4. Terumo Corporation                                        
    5. STEMCELL Technologies Inc.                          
    6. HemaCare  
    7. Macopharma
    8. AllCells
    9. BioIVT 
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo